Health Care/Hospital
Novarad's VisAR Receives FDA Clearance for Augmented Reality Surgical Navigation in Spinal Surgery in Indonesia
SALT LAKE CITY, May 13, 2023 /PRNewswire/ -- Novarad's VisAR, a surgical navigation system that uses augmented reality, has received clearance from Indonesia's FDA for intraoperative use in stereotactic spinal surgery. VisAR is accurate for both open and minimally invasive surgery (MISS). This cut...
2023-05-13 00:23
3399
LaNova Medicines Announces Global Exclusive License Agreement with AstraZeneca for LM-305, a Novel GPRC5D-Targeting Antibody Drug Conjugate
SHANGHAI, May 12, 2023 /PRNewswire/ -- LaNova Medicines Ltd. ("LaNova Medicines") announced today it has entered into an exclusive license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN), for LM-305, a pre-clinical stage antibody drug conjugate (ADC) targeting G protein-coupled receptor, class C...
2023-05-12 23:30
3879
Access to Novavax's COVID Vaccine Grows with Extended Interim Authorization for Adolescents in Singapore
GAITHERSBURG, Md., May 12, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that the Singapore Health Sciences Authority (HSA) has granted extended interim authorization and the Ministry of Heal...
2023-05-12 21:01
5248
Crystal Formulation Services' GMP Manufacturing Facility Successfully Passes the Remote Audit by US Client, Marking a Key Milestone for Its International Expansion
SUZHOU, China, May 12, 2023 /PRNewswire/ -- Today, Crystal Pharmatech announced that the GMP manufacturing facility of their CDMO business unit – Crystal Formulation Services (CFS) has successfully passed a remote audit conducted by a US client. The audit, which lasted for four days, confirmed th...
2023-05-12 21:00
2098
Zhongchao Inc. Announces Strategic Cooperation with Ximalaya
SHANGHAI, May 12, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Beijing Zhongchao Boya Medical Technology Co., Ltd. ("Boya M...
2023-05-12 20:00
2354
CRM Trial Connect 2023: Minister of Health Malaysia, Dr. Zaliha Mustafa visits Taimei Technology's booth
SHANGHAI, May 12, 2023 /PRNewswire/ -- Taimei Technology, the digital platform for life science industry, attendedCRM Trial Connect 2023 held at the InterContinental Kuala Lumpur fromMay 11 to May 12, 2023. During the event, Dr. Zaliha Mustafa, Minister of Health Malaysia visited Taimei Technolog...
2023-05-12 19:36
3846
Ageing Asia and SUSS join forces to organise the world's biggest ageing festival in Singapore across 24-25 May 2023
Over 100 world's' top gerontech solutions and launch of inaugural SUSS Geronpreneurship Innovation Festival to promote successful ageingalong Singapore's International Ageing Week SINGAPORE, May 12, 2023 /PRNewswire/ -- Ageing Asia 2023 – The World Ageing Festival (14th Edition) is co-organised ...
2023-05-12 18:38
2938
FWD Group announces Group CFO transition
HONG KONG, May 12, 2023 /PRNewswire/ -- FWD Group Holdings Limited ("FWD Group" or "the company") today announced that its Group Chief Financial Officer (CFO), Jon Nielsen, will be leaving the company to pursue a career opportunity in North America. Mr Nielsen has committed to remain with FWD Grou...
2023-05-12 17:51
3178
Results of Phase I Clinical Study of Qilu Pharma's PD-1/CTLA-4 Bifunctional Antibody Iparomlimab/Tuvonralimab Published Online in Journal of Hematology & Oncology
JINAN, China, May 12, 2023 /PRNewswire/ -- On May 8, 2023, Journal of Hematology & Oncology (JHO, 2022 impact factor of 23.168) published the results of the Phase I clinical study of Qilu Pharma's immunotherapy bifunctional antibody, QL1706 (J Hematol Oncol. 2023May 8;16(1):50). This study is the...
2023-05-12 17:40
2031
Nona Biosciences Announces Strategic Collaboration Agreement with PharmaEssentia Innovation Research Center
CAMBRIDGE, Mass., May 11, 2023 /PRNewswire/ -- Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited, committed to cutting-edge technology innovation and provider of integrated solutions from "Idea to IND" (I to I™), announced today it has entered into a strategic collaboration agre...
2023-05-12 09:32
2048
Nefecon Included in the Reimbursement Drug List of "Beijing Puhui Health Insurance Program" as a First-in-Disease Therapy for IgA Nephropathy
SHANGHAI, May 12, 2023 /PRNewswire/ -- An imported version of Nefecon (budesonide) delayed release capsule has been added to the 2023 New Reimbursement Drug List of Specialized Medicines of the "Beijing Puhui Health Insurance Program." Nefecon is a first-in-disease treatment for adults with prim...
2023-05-12 07:40
3808
Gracell Biotechnologies to Present Clinical Data on BCMA/CD19 Dual-Targeting FasTCAR-T GC012F in RRMM and B-NHL and Donor-Derived CAR-T GC007g in B-ALL at EHA2023 Congress
First disclosure of data from Phase 1 study of the donor-derived allogeneic CAR-T GC007g shows 100% overall response rate (ORR) and a favorable safety profile for treatment ofrelapsed/refractory B-cell acute lymphoblastic leukemia (r/r B-ALL) Longer-term GC012F data in relapsed/refractory multip...
2023-05-12 05:28
2208
NewFish partners with Socius Ingredients to develop algae proteins for USA sports and active nutrition market
CHICAGO, May 11, 2023 /PRNewswire/ -- NewFish has entered into a co-development partnership agreement withChicago-based Socius Ingredients to commercialise microalgae proteins and specialized ingredients targeting the active nutrition market in theUSA. The active and sports nutrition market in t...
2023-05-12 03:52
1725
Kintor Pharma Announces Successful Completion of Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia in the US
SUZHOU, China, May 11, 2023 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the Phase II clinical trial of in-house developed KX-826 for the treatm...
2023-05-11 23:30
2166
The Esaote Group presents its latest solutions for cardiac imaging at the EACVI Congress in Barcelona (Spain)
BARCELONA, Spain, May 11, 2023 /PRNewswire/ -- Esaote, one of the world's leading manufacturers of medical diagnostic systems (specifically, ultrasound, dedicated MRI and Medical IT systems) took part in the Congress held by the European Association of Cardiovascular Imaging inBarcelona on May 10...
2023-05-11 21:27
3277
CytoMed Therapeutics to Ring Nasdaq Closing Bell
SINGAPORE, May 11, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited ("CytoMed" or the "Company") (Nasdaq: GDTC), a biopharmaceutical company focused on harnessing its licensed proprietary technologies to create novel allogeneic cell-based immunotherapies for the treatment of human cancers, will ...
2023-05-11 21:00
3432
Results of Phase I Clinical Study of Qilu Pharma's PD-1/CTLA-4 Bifunctional Antibody Iparomlimab/Tuvonralimab Published Online in Journal of Hematology & Oncology
JINAN, China, May 11, 2023 /PRNewswire/ -- On May 8, 2023, the authoritative oncology journal, Journal of Hematology & Oncology (JHO, 2022 impact factor of 23.168) published the results of the Phase I clinical study of Qilu Pharma's immunotherapy bifunctional antibody, QL1706 (Title: First-in-hum...
2023-05-11 20:55
2234
Health In Tech Partners with ClaimsBridge For Network Management Services
The collaboration will provide self-funded clients with unparalleled access to providers and discounts that are unique in the industry STUART, Fla., May 11, 2023 /PRNewswire/ -- Health In Tech, an industry-leading insurtech company that delivers disruptive innovation and reimaginesself-funded he...
2023-05-11 20:30
2199
KT&G reports 2023 Q1 results, on track to become a 'global top-tier' company
* Q1 revenue of KRW 1.396 trillion, operating profit of KRW 316.5 billion * Continued robust growth in combustibles and Heat Not Burn, fundamentals intact * Overseas Heat Not Burn sales volume and operating profit up 64.3%, 127% YoY * Overseas subsidiaries sales volume and revenue up 60%, 4...
2023-05-11 19:45
3452
Invivoscribe Announces IVDR Approval of the LeukoStrat CDx FLT3 Mutation Assay
SAN DIEGO, May 11, 2023 /PRNewswire/ -- "Today we are pleased to announce that Invivoscribe's LeukoStrat® CDx FLT3 Mutation Assay has been approved by BSI ( Netherlands) and the EMA as a Class C CDx assay, meeting the stringent new IVDR (Regulation (EU) 2017/746) requirements. Invivoscribe is one ...
2023-05-11 18:00
2321
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 292 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 290 media titles]
2024-04-22 06:00
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25
Animated Life in Yunnan
[Picked up by 281 media titles]
2024-04-18 14:00
Most Read
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
2024-04-18 21:26
8827
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
8517
Animated Life in Yunnan
2024-04-18 14:00
7810
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
7314
IQAX eBL Wins Prestigious APTFF Trade Facilitation Innovation Award 2024
2024-04-18 10:36
3888